WallStreetZenWallStreetZen

NASDAQ: LXEO
Lexeo Therapeutics Inc Stock

$14.87+0.25 (+1.71%)
Updated Mar 1, 2024
LXEO Price
$14.87
Fair Value Price
$0.08
Market Cap
$396.22M
52 Week Low
$9.00
52 Week High
$22.33
P/E
N/A
P/B
-2.43x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
-0.2
Operating Cash Flow
N/A
Beta
0.13
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (23)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how LXEO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

LXEO ($14.87) is overvalued by 18,582.99% relative to our estimate of its Fair Value price of $0.08 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
LXEO ($14.87) is not significantly undervalued (18,582.99%) relative to our estimate of its Fair Value price of $0.08 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
LXEO's short-term assets ($38.87M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
There are 30 more LXEO due diligence checks available for Premium users.

Be the first to know about important LXEO news, forecast changes, insider trades & much more!

LXEO News

Valuation

LXEO fair value

Fair Value of LXEO stock based on Discounted Cash Flow (DCF)
Price
$14.87
Fair Value
$0.08
Overvalued by
18,582.99%
LXEO ($14.87) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
LXEO ($14.87) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

LXEO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
-2.43x
Industry
6.18x

LXEO's financial health

Profit margin

Revenue
$0.0
Net Income
-$20.1M
Profit Margin
0%

Assets to liabilities

Assets
$54.7M
Liabilities
$32.5M
Debt to equity
-0.2
LXEO's short-term assets ($38.87M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
LXEO's short-term assets ($38.87M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
LXEO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
LXEO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$13.9M
Investing
-$53.0k
Financing
$3.9M

LXEO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
LXEO$396.22M+1.71%N/A-2.43x
PEPG$395.78M-1.95%-6.09x3.14x
PSTX$394.93M+4.29%-2.66x3.19x
ADCT$399.77M+0.62%-2.22x-7.38x
HRTX$391.69M-1.88%-2.84x-14.10x

Lexeo Therapeutics Stock FAQ

What is Lexeo Therapeutics's quote symbol?

(NASDAQ: LXEO) Lexeo Therapeutics trades on the NASDAQ under the ticker symbol LXEO. Lexeo Therapeutics stock quotes can also be displayed as NASDAQ: LXEO.

If you're new to stock investing, here's how to buy Lexeo Therapeutics stock.

What is the 52 week high and low for Lexeo Therapeutics (NASDAQ: LXEO)?

(NASDAQ: LXEO) Lexeo Therapeutics's 52-week high was $22.33, and its 52-week low was $9.00. It is currently -33.41% from its 52-week high and 65.22% from its 52-week low.

How much is Lexeo Therapeutics's stock price per share?

(NASDAQ: LXEO) Lexeo Therapeutics stock price per share is $14.87 today (as of Mar 1, 2024).

What is Lexeo Therapeutics's Market Cap?

(NASDAQ: LXEO) Lexeo Therapeutics's market cap is $396.22M, as of Mar 3, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Lexeo Therapeutics's market cap is calculated by multiplying LXEO's current stock price of $14.87 by LXEO's total outstanding shares of 26,645,538.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.